Business
Coronavirus tracker: switching to tracking fatalities

Coronavirus tracker: switching to tracking fatalities

The United States officially has the most coronavirus cases, with almost 86,000 confirmed at the latest count. Sadly, because deaths are mounting and testing rates vary so substantially from country to country, it's becoming more prudent to track fatalities, rather than confirmed cases.

This latest version of our tracker, inspired by the work of John Burn-Murdoch, tracks the fatalities of those countries most affected. As always it reveals some hopeful, and some worrying, trends about the spread of coronavirus.

The good news

1) Italy's death count has crossed 8000, but crucially the curve is flattening, showing the effects of almost 3 weeks of full lockdown. Iran's is also slowing.

2) Australia & Canada are a fair bit earlier in their infection cycle, and may be able to flatten their curve by implementing some best practice policies (testing, social distancing) a bit earlier than other countries.

The bad news

1) The US will probably win the race that no-one wants to win, by likely becoming the first country with 100,000 cases. Its fatality curve also appears to be steepening, not getting flatter. Deaths have increased from 200 to 1209 in just 1 week, equivalent to daily growth of 29%.

2) Many other countries on lockdown, including the UK where Prime Minister Boris Johnson tested positive for coronavirus, remain on trajectories similar to that of Italy and Iran.

3) Brazil has now recorded almost 100 fatalities, with president Jair Bolsonaro arguably taking the most anti-scientific line of any world leader, arguing that Brazilians "never catch anything".

Our advice? Same as ever, keep self-isolating, keep sticking to the advice of trusted professionals and epidemiologists.

More Business

See all Business
The Sphere In Las Vegas

Washington D.C. looks set to get America’s second Sphere

Revenue for the Las Vegas version of the big orb has soared, but the sphere is still a money pit.

business

Ford reportedly in talks to buy hybrid vehicle batteries from Chinese auto giant BYD

Detroit’s Ford and China’s BYD are said to be in ongoing talks to partner on an agreement that would see Ford buy hybrid vehicle batteries from BYD, according to reporting from The Wall Street Journal.

The report comes just days after President Trump toured a Ford factory in Michigan and implied openness to Chinese automakers coming to the US.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

“If they want to come in and build a plant... that’s great, I love that,” Trump said on January 13. “Let China come in, let Japan come in.”

Last week, China’s Geely Automobile Holdings said it expects to make an announcement about expanding into the US within the next three years. Chinese carmakers currently face huge tariffs and software restrictions, effectively barring their vehicles from the US.

Ford has doubled down on hybrid vehicles amid high EV costs and the end of federal EV tax credits. The automaker is currently building a battery plant in Michigan where it plans to use tech from Chinese battery maker CATL.

Still life of Ozempic and Wegovy with weight scale.

Lawsuit alleges Lilly, Novo locked up telehealth to kill compounded GLP-1s

Novo Nordisk CEO Mike Doustdar estimated that around 1.5 million US patients are using compounded versions of the company’s drugs.

Handshake

Big Pharma enters 2026 with an appetite for deals

At the JPMorgan Healthcare Conference, biotechs and Big Pharma signaled they’re primed for M&A this year, after a big year for deals in 2025.

Latest Stories

Sherwood Media, LLC produces fresh and unique perspectives on topical financial news and is a fully owned subsidiary of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, or Robinhood Money, LLC.